期刊文献+

艾司西酞普兰与文拉法辛治疗老年焦虑症的临床疗效与安全性研究 被引量:2

Clinical Efficacy and Safety of Escitalopram and Venlafaxine in the Treatment of Senile Anxiety
下载PDF
导出
摘要 目的比较艾司西酞普兰与文拉法辛治疗老年焦虑症的临床疗效与安全性。方法选择该院精神科2017年1月-2019年4月收治的60例老年焦虑症患者,按照随机数字表法分为A组30例与B组30例,A组给予文拉法辛,B组给予艾司西酞普兰,比较临床疗效、焦虑评分、抑郁评分、睡眠质量评分、不良反应发生率。结果临床总有效率A组90.00%,B组96.67%,组间比较差异无统计学意义(χ^2=1.071,P>0.05)。治疗后,观察组、对照组的HAMA评分、HAMD评分、PSQI评分与治疗前相比均明显降低(观察组:t=8.601、8.331、7.855;对照组:t=4.636、4.601、4.209,P<0.05),B组的HAMA评分(10.47±3.19)分、HAMD评分(15.34±2.25)分、PSQI评分(10.41±1.98)分与对照组相比均更低(t=4.386、4.149、4.104,P<0.05)。不良反应发生率A组3.33%,B组0.00%,组间比较差异无统计学意义(χ^2=1.017,P>0.05)。结论艾司西酞普兰与文拉法辛用于老年焦虑症治疗中均具有良好的临床疗效和安全性,但艾司西酞普兰对患者焦虑症状、抑郁症状的缓解作用更加显著,可更好地提高患者的睡眠质量。 Objective To compare the clinical efficacy and safety of escitalopram and venlafaxine in the treatment of senile anxiety.Methods A total of 60 elderly patients with anxiety who were treated in the psychiatric department of the hospital from January 2017 to April 2019 were selected and divided into 30 cases in group A and 30 cases in group B according to the random number table method.Group A was given venlafaxine and group B was given escitalopram and compared for clinical efficacy,anxiety score,depression score,sleep quality score,and incidence of adverse reactions.Results The total clinical effective rate was 90.00%in group A and 96.67%in group B.There was no statistical difference between the groups(χ^2=1.071,P>0.05).After treatment,the HAMA score,HAMD score,PSQI score of the observation group and the control group were significantly lower than those before the treatment(The observation group:t=8.601,8.331,7.855;The control group:t=4.636,4.601,4.209,P<0.05),the HAMA score(10.47±3.19)points,HAMD score(15.34±2.25)points,and PSQI score(10.41±1.98)points of group B were lower than those of the control group(t=4.386,4.149,4.104,P<0.05).The incidence of adverse reactions was 3.33%in group A and0.00%in group B.There was no statistical difference between the groups(χ^2=1.017,P>0.05).Conclusion Both escitalopram and venlafaxine have good clinical efficacy and safety in the treatment of senile anxiety,but escitalopram has a more significant relief effect on patients’anxiety symptoms and depression symptoms,which can be better improve the patient’s sleep quality.
作者 管明 GUAN Ming(Department of Psychiatry,Laiwu Central Hospital of Xinwen Mining Group,Jinan,Shandong Province,271103 China)
出处 《系统医学》 2020年第4期27-29,共3页 Systems Medicine
关键词 老年人 焦虑症 艾司西酞普兰 文拉法辛 Elderly Anxiety Escitalopram Venlafaxine
  • 相关文献

参考文献13

二级参考文献109

  • 1刘贤臣,唐茂芹,胡蕾,王爱祯,吴宏新,赵贵芳,高春霓,李万顺.匹兹堡睡眠质量指数的信度和效度研究[J].中华精神科杂志,1996,29(2):103-107. 被引量:3442
  • 2白秋江,郑敏.选择性5-羟色胺再摄取抑制剂致不良反应文献分析[J].中国药房,2007,18(20):1583-1585. 被引量:6
  • 3张明园.精神科评定量表手册[M].2版.长沙:湖南科学技术出版社,2003:81-94. 被引量:95
  • 4张华.药物治疗心理疏导生活护理相结合成功治疗老年焦虑症1例[J].现代护士进修杂志,2010;20(7) :100-1. 被引量:2
  • 5BRAESTRUP C,SANCHEZ C.Escitalopram of unique mechanism of action[J].Inter J Psych Clin Pra,2004,9(1):11-14. 被引量:1
  • 6Buysse DJ,Reynolds C3,Monk TH. The Pittsburgh Sleep Quality Index:a new instrument for psychiatric practice and research[J].{H}Psychiatry Research,1989,(2):193-213. 被引量:1
  • 7Nierenbery AA,Adler LA,Peselow E. Trazodone for antidepressant associated insomnia[J].Am J Psychia-try,1994,(7):1069-1072. 被引量:1
  • 8Morin CM. Insomnia:psychological assessment and man-agement[M].New York:The Guilford Press,1993. 被引量:1
  • 9Bastien CH,Vallières A,Morin CM. Validation of the In-somnia Severity Index as an outcome measure for insom-nia research[J].{H}Sleep Medicine,2001,(4):297-307. 被引量:1
  • 10Morin CM,Belleville G,Bélanger L. The Insomnia Severity Index:psychometric indicators to detect insomnia cases and evaluate treatment response[J].{H}SLEEP,2011,(5):601-608. 被引量:1

共引文献2300

同被引文献11

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部